New York, NY -- (SBWIRE) -- 03/25/2013 -- StockRunway.com issues special report on the Bullish Healthcare Stocks – Rockwell Medical Inc (NASDAQ:RMTI), Dynavax Technologies Corporation (NASDAQ:DVAX),m AstraZeneca plc (ADR) (NYSE:AZN)
Rockwell Medical Inc (NASDAQ:RMTI) jumped, seemingly after it was the subject of a Seeking Alpha article titled as “Rockwell Poised for Post-Offering Bounce Ahead of Phase III Results”.
Rockwell Medical Inc(NASDAQ:RMTI) jumped +14.29% with the closing price of $4.00. The overall volume in the last trading session was 1.83 million shares. Its fifty two week range was $3.16-$10.70. The total market capitalization remained $103.44million.
The stock is ahead its 52 week low with 26.58% and its last month price volatility remained 6.99%. Its beta coefficient was 0.80 with a target price of $16.00. In its share capital, the company has 25.86 million outstanding shares while 22.51 million shares have been floated in market.
For How Long RMTI will Fight for Profitability? Read This Trend Analysis report
It has insider ownership of 8.59% with its institutional ownership remained 19.98%. Its current year earnings per share dropped with -669.32%.
Dynavax Technologies Corporation (NASDAQ:DVAX) rose after disclosing that David Novack has been appointed to the position of Senior Vice President, Operations and Quality, effective March 25, 2013.
Mr.Novack has a strong track record in manufacturing and supply chain operations, implementing multi-national commercial manufacturing and supply chain strategies for both global industry leaders and emerging companies in vaccines, diagnostics, and biopharmaceuticals. He previously had been serving at Novartis Vaccines & Diagnostics where he served most recently as the Global Head of Technical Operations and Supply Chain for Diagnostics.
Dynavax Technologies Corporation(NASDAQ:DVAX) shares went 6.28% up and closed at $2.20 in the last trading session. Its overall traded volume was 3.36 million shares. The stock’s opening price was $2.11, hitting the day high price of $2.22 and day low of $2.09.
For How Long DVAX I’s Gloss will Attract Investors? Find out via this report
DVAX has earnings per share of -$0.33. The company has -46.77% returns on assets, -64.55% returns on equity and its return on investments is -56.46%.
AstraZeneca plc (ADR) (NYSE:AZN) extended rally on Friday after revealing plan to cut some 2,300 jobs across the globe as part of a restructuring plan. The Company said that the recent jobs reduction plan was in addition to a previously announced programme reducing 1,600 jobs related to research and development announced March 18 and the elimination of 1,150 positions declared in 2012.
AstraZeneca plc (ADR)(NYSE:AZN) climbed +2.50% to close at $49.15 and its total volume in the last trading session was 4.96 million shares. In last 52 weeks, high hit was $50.14 and low price in that period was $39.72.
Will AZN Continue To Move Higher? Find Out Here
The company has outstanding shares of 1.25 billion with the total market cap of $61.35 billion and its beta value stands at 0.64 times. It has current ratio of 1.37 and its debt-to-equity ratio is 0.43.
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
For more information on this press release visit: http://www.sbwire.com/press-releases/bullish-healthcare-stocks-rockwell-medical-rmti-dynavax-technologies-dvax-astrazeneca-azn-228262.htm